Mg supplementation appears to have a beneficial role and improves glucose parameters in people with diabetes and also improves insulin-sensitivity parameters in those at high risk of diabetes
Although higher dietary intakes of magnesium ( Mg ) seem to correspond to lower diabetes incidence , research concerning Mg supplementation in people with or at risk of diabetes is limited .
Thus , we aim ed to investigate the effect of oral Mg supplementation on glucose and insulin-sensitivity parameters in participants with diabetes or at high risk of diabetes compared with placebo .
Effect of oral magnesium supplementation on physical performance in healthy elderly women involved in a weekly exercise program: a randomized controlled trial.
BACKGROUND Magnesium deficiency is associated with poor physical performance , but no trials are available on how magnesium supplementation affects elderly people 's physical performance . OBJECTIVE The aim of our study was to investigate whether 12 wk of oral magnesium supplementation can improve physical performance in healthy elderly women . DESIGN In a parallel-group , r and omized controlled trial , 139 healthy women ( mean ± SD age : 71.5 ± 5.2 y ) attending a mild fitness program were r and omly allocated to a treatment group ( 300 mg Mg/d ; n = 62 ) or a control group ( no placebo or intervention ; n = 77 ) by using a computer-generated r and omization sequence , and research ers were blinded to their grouping . After assessment at baseline and again after 12 wk , the primary outcome was a change in the Short Physical Performance Battery ( SPPB ) ; secondary outcomes were changes in peak torque isometric and isokinetic strength of the lower limbs and h and grip strength . RESULTS A total of 124 participants allocated to the treatment ( n = 53 ) or control ( n = 71 ) group were considered in the final analysis . At baseline , the SPPB scores did not differ between the 2 groups . After 12 wk , the treated group had a significantly better total SPPB score ( Δ = 0.41 ± 0.24 points ; P = 0.03 ) , chair st and times ( Δ = -1.31 ± 0.33 s ; P < 0.0001 ) , and 4-m walking speeds ( Δ = 0.14 ± 0.03 m/s ; P = 0.006 ) than did the control group . These findings were more evident in participants with a magnesium dietary intake lower than the Recommended Dietary Allowance . No significant differences emerged for the secondary outcomes investigated , and no serious adverse effects were reported . CONCLUSIONS Daily magnesium oxide supplementation for 12 wk seems to improve physical performance in healthy elderly women . These findings suggest a role for magnesium supplementation in preventing or delaying the age-related decline in physical performance
Mg supplementation appears to have a beneficial role and improves glucose parameters in people with diabetes and also improves insulin-sensitivity parameters in those at high risk of diabetes
Although higher dietary intakes of magnesium ( Mg ) seem to correspond to lower diabetes incidence , research concerning Mg supplementation in people with or at risk of diabetes is limited .
Thus , we aim ed to investigate the effect of oral Mg supplementation on glucose and insulin-sensitivity parameters in participants with diabetes or at high risk of diabetes compared with placebo .